市场调查报告书
商品编码
1287282
输血诊断市场 - 按产品(仪器、试剂和试剂盒),按应用(血型、疾病筛查),按最终用途(医院、诊断实验室、血库)及预测,2023 - 2032年Blood Transfusion Diagnostics Market - By Product (Instruments, Reagents & Kits), By Application (Blood Grouping, Disease Screening), By End-use (Hospitals, Diagnostic Laboratories, Blood Banks) & Forecast, 2023 - 2032 |
全球输血诊断市场规模将在2023-2032年显著扩大。全球蓬勃发展的医疗设备行业为市场提供了增长途径。许多发达国家和发展中国家的政府正在对医疗设备进行大量投资,以扩大其医疗基础设施。因此,这推动了对输血诊断产品的需求,从而促进了市场收入。举例来说,最近IBEF的估计表明,到2025年,印度的医疗设备市场价值可能达到500亿美元。
整个输血诊断行业根据产品、应用、最终用途和地区进行分类。
从2023年到2032年,来自仪器部分的市场份额将以可观的复合年增长率增长。最近输血仪器的进步提高了输血过程的安全性和有效性。事实上,自动血液成分分离器和细胞挽救装置现在可以提取特定的血液成分,减少全血输注的需要,并将不良反应的风险降到最低。此外,接受外科手术的人显著增加,增加了对输血仪器的需求,如血袋、输液泵等,推动了业务增长。
就应用而言,到2032年,输血诊断的市场价值中来自血型的部分将大幅增长。血型鉴定的持续进步促进了该领域的增长。分子血型基因分型通过提供一种基于DNA的方法来确定血型,已经彻底改变了输血医学。这项技术涉及识别与血型有关的遗传变异和特定等位基因,从而实现精确和可靠的血型鉴定。
基于终端用途,血库部分的输血诊断市场将在2023-2032年获得巨大收益。世界各地的血库数量不断增加,为该领域的增长创造了广阔的空间。此外,这些设施中先进设备的高度可用性使输血更容易,进一步加强了该领域的前景。此外,对严格筛选和测试程序的需求不断增加,以确保献血的安全,这增加了对血库的需求,从而有利于市场增长。
从2023年到2032年,亚太地区输血诊断行业将以明显的复合年增长率增长。不断增长的医疗保健行业,加上该地区老年人口的增加,有利于行业的增长。根据世界卫生组织,到2040年,中国将有超过28%的人超过60岁。此外,该地区血库数量的增加也进一步增加了对输血诊断的需求。
Global Blood Transfusion Diagnostics Market size will expand significantly over 2023-2032. The flourishing medical device industry globally is presenting growth pathways for the market. Many governments in developed and developing countries are investing significant amounts into medical devices to expand their healthcare infrastructure. This, in consequence, has propelled the demand for blood transfusion diagnostic products, thus, contributing to market revenue. To illustrate, recent IBEF estimates suggest that the medical device market in India could be worth USD 50 billion by 2025.
The overall blood transfusion diagnostics industry is classified based on product, application, end-use, and region.
The market share from the instruments segment will grow at a considerable CAGR from 2023 to 2032. Recent advancements in blood transfusion instruments have improved the safety and efficacy of the transfusion process. In fact, automated blood component separators and cell salvage devices now allow for the extraction of specific blood components, reducing the need for whole blood transfusions and minimizing the risk of adverse reactions. Moreover, a remarkable rise in people undergoing surgical procedures has increased the need for blood transfusion instruments, such as blood bags, infusion pumps, and others, driving business growth.
In terms of application, the blood transfusion diagnostics market value from the blood grouping segment will grow substantially through 2032. Consistent advancements in blood grouping are contributing to segment growth. Molecular blood group genotyping has revolutionized transfusion medicine by providing a DNA-based method for determining blood types. This technique involves identifying genetic variations and specific alleles associated with blood groups, allowing for precise and reliable blood typing.
Based on end use, the blood transfusion diagnostics market from the blood banks segment will register huge gains over 2023-2032. Growing number of blood banks across the world is creating a broad scope for segment growth. Moreover, the high availability of advanced equipment in these facilities has made transfusion easier, further strengthening the segment outlook. Moreover, the growing need for rigorous screening and testing procedures to ensure the safety of donated blood has increased the demand for blood banks, thus, favoring market growth.
Asia Pacific blood transfusion diagnostics industry will grow at a significant CAGR from 2023 to 2032. Growing healthcare industry, coupled with the increasing geriatric population in the region, is working in favor of industry growth. As per WHO, over 28% of people in China will be over 60 years of age by 2040. Moreover, the rising number of blood banks in the region has further increased the need for blood transfusion diagnostics.